Literature DB >> 23163744

High expression of KIBRA in low atypical protein kinase C-expressing gastric cancer correlates with lymphatic invasion and poor prognosis.

Yohei Yoshihama1, Yusuke Izumisawa, Kazunori Akimoto, Yoshinori Satoh, Taichi Mizushima, Kei Satoh, Kazuhiro Chida, Ryo Takagawa, Hirotoshi Akiyama, Yasushi Ichikawa, Chikara Kunisaki, Yoshiaki Inayama, Itaru Endo, Yoji Nagashima, Shigeo Ohno.   

Abstract

Overexpression of atypical protein kinase Cλ/ι (aPKCλ/ι), a regulator of cell polarity, is frequently associated with the poor prognoses of several cancers, including gastric cancer. Recent studies revealed a molecular link between aPKC and KIBRA, an upstream regulator of tumor suppressor Hippo pathway that regulates cell proliferation and apoptosis. Further, KIBRA directly inhibits the kinase activity of aPKC to regulate epithelial cell polarity. These observations suggest that the KIBRA-aPKC connection plays a role in cancer progression; however, clinical significance of the correlation between these factors remains unclear. Here we examined the correlation between KIBRA/aPKCλ/ι expression, as detected by immunohistochemistry, and clinicopathological outcomes in 164 gastric cancer patients using Fisher's exact test and Kaplan-Meier log-rank test. We found an intimate correlation between the expression level of KIBRA and aPKCλ/ι (P = 0.012). Furthermore, high expression of KIBRA is correlated with lymphatic (P = 0.046) and venous invasion (P = 0.039). The expression level of KIBRA by itself did not correlate with the prognosis; however, high expression of KIBRA in low aPKCλ/ι-expressing gastric cancer correlated with disease-specific (P = 0.037) and relapse-free survival (P = 0.041) by Kaplan-Meier with log-rank test and higher lymphatic invasion cases by Fisher's exact test (P = 0.042). Furthermore, overexpression of the aPKC-binding region of KIBRA disrupted tight junctions in epithelial cells. These results suggest that high expression of KIBRA in low aPKC-expressing cells causes massive loss of aPKC activity, leading to loss of polarity and invasiveness of gastric cancer cells.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23163744     DOI: 10.1111/cas.12066

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  9 in total

1.  Candidate genes in quantitative trait loci associated with absolute and relative kidney weight in rats with Inherited Stress Induced Arterial Hypertension.

Authors:  Olga E Redina; Svetlana E Smolenskaya; Leonid O Klimov; Arcady L Markel
Journal:  BMC Genet       Date:  2015-02-02       Impact factor: 2.797

2.  Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.

Authors:  Shuping Yang; Ming Ji; Lin Zhang; Yuanhong Chen; Dirk Oliver Wennmann; Joachim Kremerskothen; Jixin Dong
Journal:  Cell Signal       Date:  2013-11-19       Impact factor: 4.315

3.  KIBRA promotes prostate cancer cell proliferation and motility.

Authors:  Seth Stauffer; Xingcheng Chen; Lin Zhang; Yuanhong Chen; Jixin Dong
Journal:  FEBS J       Date:  2016-04-05       Impact factor: 5.542

4.  KIBRA: In the brain and beyond.

Authors:  Lin Zhang; Shuping Yang; Dirk Oliver Wennmann; Yuanhong Chen; Joachim Kremerskothen; Jixin Dong
Journal:  Cell Signal       Date:  2014-03-15       Impact factor: 4.315

Review 5.  The Regulatory Role of KIBRA and PTPN14 in Hippo Signaling and Beyond.

Authors:  Kayla E Wilson; Nuo Yang; Ashley L Mussell; Jianmin Zhang
Journal:  Genes (Basel)       Date:  2016-05-27       Impact factor: 4.096

6.  KIBRA attains oncogenic activity by repressing RASSF1A.

Authors:  Lakshmi Arivazhagan; Rohan Prasad Surabhi; Archana Kanakarajan; Sandhya Sundaram; Ravi Shankar Pitani; Lakmini Mudduwa; Joachim Kremerskothen; Ganesh Venkatraman; Suresh K Rayala
Journal:  Br J Cancer       Date:  2017-06-29       Impact factor: 7.640

7.  Lack of an association between the aPKCλ/ι expression in prostate cancer and the patient outcomes.

Authors:  Yumiko Yokomizo; Takashi Kawahara; Yoji Nagashima; Hitoshi Ishiguro; Ikuma Kato; Masahiro Yao; Hiroshi Miyamoto; Hiroji Uemura
Journal:  Int J Surg Case Rep       Date:  2017-06-29

Review 8.  WWC Proteins: Important Regulators of Hippo Signaling in Cancer.

Authors:  Verena Höffken; Anke Hermann; Hermann Pavenstädt; Joachim Kremerskothen
Journal:  Cancers (Basel)       Date:  2021-01-15       Impact factor: 6.639

Review 9.  Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature.

Authors:  Anello Marcello Poma; Liborio Torregrossa; Rossella Bruno; Fulvio Basolo; Gabriella Fontanini
Journal:  Sci Rep       Date:  2018-07-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.